Swiss National Bank Purchases New Stake in Capricor Therapeutics Inc (NASDAQ:CAPR)
Swiss National Bank acquired a new position in shares of Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 67,400 shares of the biotechnology company’s stock, valued at approximately $930,000. Other large investors have […]
Swiss National Bank acquired a new position in shares of Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 67,400 shares of the biotechnology company’s stock, valued at approximately $930,000. Other large investors have […]
